NewsAvi Kapoor
Lyra Therapeutics
LYRA · NASDAQ
$0.19−$0.16 (−45.71%)TodayMarket closed ·
Prev close $0.35
Latest news
- NewsAvi Kapoor
US Stocks Lower; Dow Tumbles Over 250 Points
- Press releaseGlobe Newswire
Lyra Therapeutics Announces Clinical Plan for LYR-210 and Late-Breaking Oral Presentation of Phase 3 ENLIGHTEN 2 Study
- NewsVandana Singh
Upstream's New Sinus Treatment Cuts Need For Surgery, Early Trial Finds
- Press releaseGlobe Newswire
Lyra Therapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate Update
- News
12 Health Care Stocks Moving In Friday's Intraday Session
- News
12 Health Care Stocks Moving In Wednesday's Intraday Session
- News
12 Health Care Stocks Moving In Tuesday's After-Market Session
- NewsRishabh Mishra
US Stocks Likely To Open Lower: Expert Highlights Technical Analysis Showing S&P 500's 'Recovery Is Real' And Not A 'Bull Trap' Or 'Bear Market Rally'
- NewsAvi Kapoor
Nasdaq Surges Over 100 Points Despite Renewed Trade Concerns: Investor Sentiment Improves, Fear Index Remains In 'Greed' Zone
- NewsShivdeep Dhaliwal
Applied Digital Corp, Meta Platforms, Alphabet, Lyra Therapeutics, Tesla: Why These 5 Stocks Are On Investors' Radars Today
- News
12 Health Care Stocks Moving In Monday's Intraday Session
- NewsAvi Kapoor
Nasdaq Edges Higher; ISM Manufacturing PMI Falls In May
- NewsAvi Kapoor
Dow Dips Over 300 Points; Campbell's Posts Upbeat Earnings
- NewsVandana Singh
Why Is Lyra Therapeutics Stock Surging Over 400% On Monday?
- News
12 Health Care Stocks Moving In Monday's Pre-Market Session
- News
Market-Moving News for June 2nd
- Press releaseGlobe Newswire
Lyra Therapeutics Reports Positive Results from the ENLIGHTEN 2 Phase 3 Trial of LYR-210 Achieving Statistically Significant Results for Primary and Key Secondary Endpoints in the Treatment of Chronic Rhinosinusitis (CRS)
- News
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
- NewsRishabh Mishra
US Stocks Likely To Open Lower After S&P 500's Six-Day Streak: 'Quick Recoveries Tend To See Stocks Rally More Over The Next 3-12 Months,' Says Expert
- News
12 Health Care Stocks Moving In Wednesday's Intraday Session
- Press releaseGlobe Newswire
Lyra Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update
- Press releaseBusiness Wire
Incendia Therapeutics Appoints Bradford Smith as Chief Financial Officer
- Press releaseGlobe Newswire
Lyra Therapeutics Reports Second Quarter 2024 Financial Results and Provides Corporate Update
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.